ASH Clinical News ACN_4.12_SUPP_web | Page 5

IT’S TIME TO
CHALLENGE
Our Understanding of
Transfusion-Dependent
β-Thalassemia (TDT)
Chronic transfusions enable
survival and suppress symptoms,
but many people with TDT
experience iron overload, serious
comorbidities, decreased quality
of life and increased early
mortality. 1-3
Learn more at
ChallengeTDT.com
1. Bonifazi F, et al., Curr Med Res Opin. 2017. 2. Sobota A, et al. Am J Hematol. 2011. 3. Ladis V, et al., Eur J Haematol. 2011.
bluebird bio and the bluebird bio logo are trademarks of bluebird bio, Inc.
© bluebird bio, Inc. 2018. All rights reserved. NP-US-0002 8/18